13G Filing: Armistice Capital and Strongbridge Biopharma PLC (SBBP)

Page 5 of 11

Page 5 of 11 – SEC Filing

CUSIP No G85347105
Item 1. (a). Name of Issuer:
Strongbridge Biopharma plc
(b). Address of Issuer’s Principal Executive Offices:

900 Northbrook Drive, Suite 200

Trevose, Pennsylvania 19053

United States of America

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Ordinary Shares, par value $0.01 per share
(e). CUSIP Number:
G85347105

Follow Strongbridge Biopharma Plc

Page 5 of 11